For those who inquired about its authorship, these are the IBD timeline graphs I created! Feel free to use it if it benefits you! 📎Attached are both the complete version in a single slide and the separated version for your convenience. #IBD #MedEd

Billions worldwide consume inadequate levels of micronutrients critical to human health from food (without fortification or supplementation), modelling study in The Lancet Global Health suggests. Explore the data ▶️ hubs.li/Q02N87xd0

Congratulations on this work! This is such an interesting thing what you have addressed 🤩 Miguel Montoro will enjoy this

What is the significance of pouch body anastomotic ulcers?🧐 ⭐️ >1100 pouchoscopy procedures ⭐️ 6.5% had anastomotic ulcers, 2.2% isolated 🚫 NO ⬆️ risk of pouchitis or pouch failure academic.oup.com/ibdjournal/art… Michael Plietz Maia Kayal MD

Read the #GUTRecentAdvancesInBasicScience paper by Maria Manuela Estevinho et al on "Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms" bit.ly/4757iK3 @manasiagrawalmd Jean-Frederic Colombel Vishal Midya Shirley Cohen

🚨 New #Hpylori guidelines are available! 🔹 Focus on: • Updated tx recs • Antibiotic testing • Post-tx test for eradication confirmation William Chey Shailja Shah, MD MPH ACG AJG - The American Journal of Gastroenterology

Pancreatic cystic lesion NEJM 👇🏿 nejm.org/doi/full/10.10…

Real world data on the effectiveness of #risankizumab in refractory #Crohn's disease. Access the paper here: bit.ly/4eac0Zo Benjamin Zare Beatriz Gros Charlie Lees Mark Samaan and colleagues. BSG BSG Trainees Phil Smith Gio McGinty Vivek Goodoory

It has been great to collaborate in this study and even greater to see how risankizumab could work in patients with Crohns disease who had no other therapeutic options at that time 🤩 Charlie Lees Mark Samaan Benjamin Zare

The October issue of The Lancet Gastroenterology & Hepatology is out today! A summary of its contents👉 linkedin.com/posts/rob-brie… #GITwitter #LiverTwitter #OncTwitter #MedTwitter

From Charlie Lees Beatriz Gros et. al. Rizankizumab en pacientes con EC refractaria. instagram.com/stories/dr.bea…

Delighted to announce that I've been awarded an European Research Council (ERC) Starting Grant of ~1.5M € for my project FORECAST. I will develop in the next 5y a new framework using multiple sources of #RWD to assess the benefit-risk balance of #IBD treatments. #ERCStG erc.europa.eu/news-events/ne…

Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: the ERIC study CD patients from Saint-Antoine and Beaujon Hospital comparing Early vs Late resections onlinelibrary.wiley.com/doi/10.1111/ap… roypounder.apt Philippe Seksik Julien Kirchgesner Harry Sokol

New CPU in CGH ➡️ Expert advice on intestinal ultrasound (IUS) for #IBD. Authored by Mallory Chavannes, MD, MHSc, Michael Todd Dolinger, MD MBA, Shirley Cohen and Bincy Abraham, MD, MS, this CPU covers IUS techniques, current practices and how to overcome barriers to implementation. ow.ly/yI7g50TfJv9

New content online: Hepatic immune regulation and sex disparities dlvr.it/TCtBrG

In this new population-based study, we found higher complication rates but limited use of steroid-sparing medications and surgery in patients with very late-onset IBD (diagnosed after age 70) compared to those diagnosed between the ages of 60-69. ➡️ cghjournal.org/article/S1542-…

I remember exactly the day and time during Christmas in 2020 when you tweeted a clinical fellow offer to work in Edinburgh That day changed my life forever

Totally agree

Loss of DOCK2 potentiates #IBD –associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression Congratulations to Antonia Churchhouse for this big project 🤩 together with ShahidaDin and rest of authors nature.com/articles/s4138…

Excited to share my PhD work from Myant Lab, published today in @Oncogene Full text (open access): nature.com/articles/s4138… Summary blog: communities.springernature.com/posts/loss-of-…